These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36682412)

  • 1. A low-carbohydrate diet induces hepatic insulin resistance and metabolic associated fatty liver disease in mice.
    Long F; Bhatti MR; Kellenberger A; Sun W; Modica S; Höring M; Liebisch G; Krieger JP; Wolfrum C; Challa TD
    Mol Metab; 2023 Mar; 69():101675. PubMed ID: 36682412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the impacts of ketogenic diet on reversible hepatic steatosis: initial analysis in male mice.
    Ravaut G; Carneiro A; Mounier C
    Front Nutr; 2024; 11():1290540. PubMed ID: 38577162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term feeding of a ketogenic diet induces more severe hepatic insulin resistance than an obesogenic high-fat diet.
    Grandl G; Straub L; Rudigier C; Arnold M; Wueest S; Konrad D; Wolfrum C
    J Physiol; 2018 Oct; 596(19):4597-4609. PubMed ID: 30089335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
    Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J
    J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term ketogenic diet causes glucose intolerance and reduced β- and α-cell mass but no weight loss in mice.
    Ellenbroek JH; van Dijck L; Töns HA; Rabelink TJ; Carlotti F; Ballieux BE; de Koning EJ
    Am J Physiol Endocrinol Metab; 2014 Mar; 306(5):E552-8. PubMed ID: 24398402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition.
    Krishnan A; Abdullah TS; Mounajjed T; Hartono S; McConico A; White T; LeBrasseur N; Lanza I; Nair S; Gores G; Charlton M
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G666-G680. PubMed ID: 28232454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitis.
    Duparc T; Briand F; Trenteseaux C; Merian J; Combes G; Najib S; Sulpice T; Martinez LO
    Am J Physiol Gastrointest Liver Physiol; 2019 Oct; 317(4):G508-G517. PubMed ID: 31460789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ketogenic diet prevents steatosis and insulin resistance by reducing lipogenesis, diacylglycerol accumulation and protein kinase C activity in male rat liver.
    Jani S; Da Eira D; Stefanovic M; Ceddia RB
    J Physiol; 2022 Sep; 600(18):4137-4151. PubMed ID: 35974660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
    Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
    Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet.
    Garbow JR; Doherty JM; Schugar RC; Travers S; Weber ML; Wentz AE; Ezenwajiaku N; Cotter DG; Brunt EM; Crawford PA
    Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G956-67. PubMed ID: 21454445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation.
    Ganz M; Csak T; Szabo G
    World J Gastroenterol; 2014 Jul; 20(26):8525-34. PubMed ID: 25024607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, β-cryptoxanthin.
    Ni Y; Nagashimada M; Zhan L; Nagata N; Kobori M; Sugiura M; Ogawa K; Kaneko S; Ota T
    Endocrinology; 2015 Mar; 156(3):987-99. PubMed ID: 25562616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoplasmic reticulum stress does not contribute to steatohepatitis in obese and insulin-resistant high-fat-diet-fed foz/foz mice.
    Legry V; Van Rooyen DM; Lambert B; Sempoux C; Poekes L; Español-Suñer R; Molendi-Coste O; Horsmans Y; Farrell GC; Leclercq IA
    Clin Sci (Lond); 2014 Oct; 127(7):507-18. PubMed ID: 24766485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to ambient particulate matter induces a NASH-like phenotype and impairs hepatic glucose metabolism in an animal model.
    Zheng Z; Xu X; Zhang X; Wang A; Zhang C; Hüttemann M; Grossman LI; Chen LC; Rajagopalan S; Sun Q; Zhang K
    J Hepatol; 2013 Jan; 58(1):148-54. PubMed ID: 22902548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1.
    Wu L; Liu Y; Zhao Y; Li M; Guo L
    Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis.
    Bae CR; Hino J; Hosoda H; Miyazato M; Kangawa K
    Life Sci; 2018 Sep; 209():349-356. PubMed ID: 30114411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fgf21 impairs adipocyte insulin sensitivity in mice fed a low-carbohydrate, high-fat ketogenic diet.
    Murata Y; Nishio K; Mochiyama T; Konishi M; Shimada M; Ohta H; Itoh N
    PLoS One; 2013; 8(7):e69330. PubMed ID: 23874946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in mice.
    Bluemel S; Wang Y; Lee S; Schnabl B
    World J Gastroenterol; 2020 Sep; 26(33):4933-4944. PubMed ID: 32952340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.
    Liu C; Schönke M; Spoorenberg B; Lambooij JM; van der Zande HJP; Zhou E; Tushuizen ME; Andreasson AC; Park A; Oldham S; Uhrbom M; Ahlstedt I; Ikeda Y; Wallenius K; Peng XR; Guigas B; Boon MR; Wang Y; Rensen PCN
    Elife; 2023 Jan; 12():. PubMed ID: 36648330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis.
    Pejnovic N; Jeftic I; Jovicic N; Arsenijevic N; Lukic ML
    World J Gastroenterol; 2016 Nov; 22(44):9706-9717. PubMed ID: 27956794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.